Blood Glucose at Altitude: What Happens at 30,000 Feet?

In the ever-evolving landscape of diabetes medicine, the transition from reactive to proactive management is no longer a distant ideal, but a clinical reality. Our next live medical CME invites the diabetes care team to explore and reflect on the profound clinical and personal shifts catalysed by advanced technology.

We will anchor our discussion in two ground-breaking studies that challenge our traditional boundaries of care. First, we examine the INRANGE real-world data, which demonstrates that 12 months of Tandem Control-IQ use significantly increases Time in Range (TIR) from 58.8% to 70.9%. This isn’t just a statistical victory, it translates to a profound reduction in severe hypoglycaemic events and work absenteeism, reclaiming time and safety for people with diabetes.

Secondly, we push the limits of occupational safety through the lens of the SUNDIF metabolic study. By assessing CGM performance in hypobaric flight simulations, we discover that modern sensors maintain clinical accuracy even under the atmospheric stresses of aviation. This evidence-based reassurance allows us to advocate for our patients in high-stakes environments, ensuring their diagnosis does not ground their aspirations!

We are moving beyond A1c toward time in tight range & person-reported outcomes. Philosophically, we are witnessing a ‘digital liberation’. As healthcare professionals, our role is shifting from that of a “regulator” to a “navigator,” helping our patients steer through a world that is increasingly automated yet remains deeply personal.